Nisa Investment Advisors’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.63K Sell
2,693
-5,619
-68% -$9.67K ﹤0.01% 2463
2025
Q1
$27.7K Buy
8,312
+377
+5% +$1.26K ﹤0.01% 1763
2024
Q4
$58.7K Sell
7,935
-374
-5% -$2.77K ﹤0.01% 1641
2024
Q3
$78K Buy
8,309
+235
+3% +$2.21K ﹤0.01% 1515
2024
Q2
$64.8K Buy
8,074
+332
+4% +$2.66K ﹤0.01% 1588
2024
Q1
$115K Buy
7,742
+201
+3% +$2.98K ﹤0.01% 1433
2023
Q4
$61.3K Buy
7,541
+5,577
+284% +$45.3K ﹤0.01% 1584
2023
Q3
$8.94K Sell
1,964
-3,872
-66% -$17.6K ﹤0.01% 2192
2023
Q2
$41.1K Buy
5,836
+1,965
+51% +$13.8K ﹤0.01% 1817
2023
Q1
$24K Buy
3,871
+1,995
+106% +$12.4K ﹤0.01% 1954
2022
Q4
$12K Sell
1,876
-4,562
-71% -$29.2K ﹤0.01% 2168
2022
Q3
$60K Sell
6,438
-176
-3% -$1.64K ﹤0.01% 1680
2022
Q2
$73K Buy
6,614
+6,190
+1,460% +$68.3K ﹤0.01% 1597
2022
Q1
$7K Hold
424
﹤0.01% 2257
2021
Q4
$7K Sell
424
-396
-48% -$6.54K ﹤0.01% 2067
2021
Q3
$20 Sell
820
-5,549
-87% -$135 ﹤0.01% 2095
2021
Q2
$166 Hold
6,369
﹤0.01% 1470
2021
Q1
$202 Hold
6,369
﹤0.01% 1485
2020
Q4
$296K Buy
6,369
+578
+10% +$26.9K ﹤0.01% 1331
2020
Q3
$191K Sell
5,791
-454
-7% -$15K ﹤0.01% 1321
2020
Q2
$171K Buy
6,245
+5,384
+625% +$147K ﹤0.01% 1320
2020
Q1
$26K Buy
861
+160
+23% +$4.83K ﹤0.01% 1661
2019
Q4
$19K Hold
701
﹤0.01% 1699
2019
Q3
$13K Sell
701
-249
-26% -$4.62K ﹤0.01% 1718
2019
Q2
$23K Hold
950
﹤0.01% 1585
2019
Q1
$9K Sell
950
-250
-21% -$2.37K ﹤0.01% 1787
2018
Q4
$11K Buy
1,200
+690
+135% +$6.33K ﹤0.01% 1628
2018
Q3
$6K Sell
510
-190
-27% -$2.24K ﹤0.01% 1849
2018
Q2
$9K Hold
700
﹤0.01% 1757
2018
Q1
$12K Buy
+700
New +$12K ﹤0.01% 1596